Physician profile
Beth E Lin
NPI 1457639239
$2,804.51
in general payments reported to CMS, 2019-2025
20 companies · $45.40 in 2025
The $45.40 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $338 · 2021: $135 · 2022: $869 · 2023: $332 · 2024: $524 · 2025: $45.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501 · Gift: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.44 |
| Gift | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $400.00 | 2024 | |
| Allergan, INC. | $354.31 | 2019-2022 | |
| Coopervision INC. | $305.47 | 2019-2023 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $273.33 | 2019-2020 | |
| Abbvie INC. | $251.96 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $211.47 | 2022-2024 | Infuse, Xiidra |
| Novartis Pharmaceuticals Corporation | $174.16 | 2019-2022 | |
| Alcon Vision LLC | $151.96 | 2022-2023 | Hydrus Microstent |
| Aerie Pharmaceuticals, INC. | $151.89 | 2019 | |
| Dompe US, INC. | $84.58 | 2023 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $84.22 | 2019 | |
| Astellas Pharma US INC | $76.95 | 2024-2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $66.21 | 2019-2020 | |
| Biotissue Holdings INC. | $63.72 | 2021-2025 | |
| Sight Sciences, INC. | $45.44 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $30.53 | 2021 | |
| Amgen INC. | $27.00 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $19.54 | 2022 | |
| Shire North American Group INC | $17.77 | 2019 | |
| Akorn, INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.